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Available online 12 March 2019Hybrid wound dressings have been constructed using two biomaterials: bacterial cellulose (BC) and copolymer
of 3-hydroxybutyric and 4-hydroxybutyric acids [P(3HB/4HB)] – a biodegradable polymer of microbial origin.
Some of the experimental membranes were loaded with drugs promoting wound healing and epidermal cells
differentiated frommultipotent adipose-derivedmesenchymal stem cells. A study has been carried out to inves-
tigate the structure and physical/mechanical properties of the membranes. The in vitro study showed that the
most effective scaffolds for growing ﬁbroblasts were composite BC/P(3HB/4HB) ﬁlms loaded with actovegin.
Two types of the experimental biotechnological wound dressings – BC/P(3HB/4HB)/actovegin and BC/P(3HB/
4HB)/ﬁbroblasts – were tested in vivo, on laboratory animals with model third-degree skin burns. Wound
planimetry, histological examination, and biochemical and molecular methods of detecting factors of angiogen-
esis, inﬂammation, type I collagen, and keratin 10 and 14 were used to monitor wound healing. Experimental
wound dressings promoted healing more effectively than VoskoPran – a commercial wound dressing.
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Facilitating skin wound healing by using new technologies and ma-
terials is one of the main challenges facing science and clinical practice.
231T.G. Volova et al. / International Journal of Biological Macromolecules 131 (2019) 230–240Hundreds of surgical and therapeutic materials and tools can be used to
reconstruct skin defects. Considerable research effort is being placed on
natural and synthetic polymers (derivatives of methyl methacrylate,
dextran, acrylamide, agar-agar, etc.) [1]. Thesematerials are used to pro-
duce sponges, ﬁlm coatings, and gel-forming coatings, which can be ap-
plied in Phases II and III of the healing process [2].
The properties of the material used to fabricate wound dressings
must correspond to the type of the injury and to the development and
phase of the healing process. Fabrication of biotechnological dermal
equivalents carrying cells is a rapidly developing line of research
aimed at reconstructing skin defects. The main challenge facing re-
searchers is the choice ofmaterials, which should have a number of spe-
cial properties and impart characteristics of living tissues to the
engineered constructs (grafts). These characteristics include 1) the abil-
ity to regenerate themselves, 2) the ability tomaintain the blood supply,
and 3) the ability to alter their structure and properties in response to
effects of the external factors, including mechanical loads [3].
Bacterial cellulose (BC) and bioresorbable polyhydroxyalkanoates
(PHAs) are promising materials for reconstructive biomedical technolo-
gies including tissue engineering. BC shows high biocompatibility, with-
out being cytotoxic or causing any allergic reactions in vivo; it has unique
structure and physical/mechanical properties including highmechanical
strength, elasticity, gas permeability, goodwater holding capacity, poros-
ity, etc. The BC structure and high biocompatibility suggest that this nat-
ural polymer can be useful for reconstructive surgery asmaterial for skin
defect reconstruction and as a matrix for drug delivery [4–9].
A number of studies showed the effectiveness of using BC alone and
BC composites with various materials in reconstructing skin defects.
Cellulose impregnated with lidocaine considerably facilitated healing
of third-degree burns [7]. Full-thickness skin wounds in rats healed ef-
fectively under a ﬁlm of BC nanocrystals/chitosan incorporating silver
and curcuminparticles [10]. BC scaffoldswith curcumin particles encap-
sulated in chitosan and in compositionwith gelatin andﬁbrinwere used
tomanage skinwounds inmice and rats [11–13]. Singla et al. [14] inves-
tigated hydrogels prepared from bamboo cellulose nanocrystals loaded
with silver particles, which successfully healed skin wounds in diabetic
mice. Other authors tested gels based on cellulose and acrylate loaded
with ﬁbroblasts and keratinocytes, which considerably accelerated the
healing of model burns and synthesis of type 1 collagen [15,16].
P(3HB/4HB) is one of the most attractive representatives of
polyhydroxyalkanoates (PHAs). PHAs are biopolymers of microbial ori-
gin,which are biodegradable, highly biocompatible, and effective in var-
ious biomedical applications. PHAs have been successfully tested as
resorbable surgical sutures [17], artiﬁcial pericardium [18], wound
dressings [19], implants for repairing cranial defects [20], biocompatible
coatings for metallic stents [21], fully resorbable stents [22], biliary
stents [23], etc. [24–26]. Thus, each of these biomaterials (BC and
PHA) can be used to regenerate tissues, including skin.
One of the new lines of research is constructing composite materials
and implants based on BC and PHA to repair tissue defects. Preparation
of the BC/PHA composite materials and their characterization are de-
scribed in a number of studies [27–32].
The purpose of the present study was to construct and investigate
composites based on BC and PHA as biotechnological wound dressings
and to evaluate their efﬁcacy in managing model skin burns in experi-
ments with laboratory animals.
2. Experimental
2.1. Materials
Bacterial cellulose ﬁlms were synthesized in the Komagataei
bacterxylinus B-12068 culture. The strain was isolated from the
fermented tea (kombucha) Medusomyces gisevii J. Lindauon Hestrin-
Schramm (HS) medium. The strain was identiﬁed based on its morpho-
logical, biochemical, genetic, and growth parameters. The strainKomagataeibacter xylinuswas deposited in the Russian National Collec-
tion of Industrial Microorganisms (VKPM) with registration number
VKPM B-12068. The collection culture of K. xylinus B-12068 was main-
tained on the Hestrin-Schramm (HS) agar medium. The standard HS
medium contained (% w/v): glucose – 2, peptone – 0.5, yeast extract –
0.5, Na2HPO40.27, and citric acid – 0.115. The pre-culture was per-
formed on the HS agar. Then, the colonies were transferred into the
ﬂask containing liquidHSmediumand cultivated for 7 days at a temper-
ature of 30 °C under static conditions. To remove remnants of bacterial
cells and components of culture medium, BC ﬁlms were treated with
1.0 M NaOH at 70 °C, followed by washing in deionized water. The syn-
thesized cellulose was separated from the culture ﬂuid. Then, BC ﬁlms
were placed in a 0.5% solution of hydrochloric acid for 24 h for neutral-
ization and, afterwards, rinsed in distilled water until pH 7. The BC ﬁlms
were stored in sterile solution or air dried until they reached a stable
weight.
In the present study, PHA copolymers comprising monomers of 3-
hydroxybutyric and 4-hydroxybutyric acids [P(3HB/4HB)] were used.
This is the best PHA for fabricating biomedical products: P(3HB/4HB)
has a low degree of crystallinity, the highest elasticity, and the fastest
rate of biodegradation in vivo. The polymer was synthesized in
Cupriavidus eutrophus B10646microbial culture (the strain is registered
in the Russian Collection of Industrial Microorganisms) [31]. Cells were
batch-cultured in a 14-L New Brunswick Scientiﬁc BioFlo 110 fermentor
ﬁlled to 40% of its volume with standard mineral salt medium:
Na2HPO4·H2O – 9.1; KH2PO4 – 1.5; MgSO4·H2O – 0.2; Fe3C6H5O7·7H2O
– 0.025; NH4Cl – 0.5 (g/L); themediumwas supplementedwith glucose
in amounts corresponding to cell concentration in the medium. A solu-
tion of iron citrate (5 g/L) was used as a source of iron. Hoagland's trace
element solution was used: 3 ml of standard solution per 1 L of theme-
dium. The standard solution contained H3BO3 – 0.288; CoCl2·6H2O –
0.030; CuSO4·5H2O – 0.08; MnCl2·4H2O – 0.008; ZnSO4·7H2O –
0.176; NaMoO4·2H2O – 0.050; NiCl2 – 0.008 (g/L). In order to achieve
synthesis of P(3HB/4HB) copolymer, the culture medium was supple-
mented with additional carbon substrate (γ-butyrolactone).
2.2. Constructing BC/P(3HB/4HB) composites as wound dressings
Composites were prepared from BC ﬁlms or powder and solutions of
poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB/4HB)] (85mol
% 3HB/15 mol% 4HB). BC/P(3HB/4HB) hybrids were constructed using
different methods: 1) dried BC pellicles and wet (chloroform-impreg-
nated) BC pellicles were soaked in 2% and 5% P(3HB/4HB) solutions in
chloroform; 2) dried BC pellicles were soaked in a 2% P(3HB/4HB) solu-
tion in chloroform, kept there for 24 h, and dried in a dust-free cabinet
until the solvent had completely evaporated; 3) nonwovenmembranes
were placed into the K. xylinus B-12068 culture, and bacterial cellulose
synthesized in it grew on the surface of the membranes under static
conditions; 4) powdered cellulose (particle size of 120 μm) was added
to a 3% P(3HB/4HB) solution in chloroform and mixed ultrasonically
to homogeneity; then, ﬁlms were produced by the solvent evaporation
technique, at polymer to cellulose ratios of 2:1 and 1:1; 5) P(3HB/4HB)
powder was added to the K. xylinus B-12068 culture; and 6) a ﬁlm of
bacterial cellulose grew on nonwoven membranes in the submerged
culture of K. xylinus B-12068.
2.3. A study of the structure and physical properties of BC/P(3HB/4HB)
The thickness of composites was measured with a LEGIONER EDM-
25-0.001 electronic digital micrometer (Legioner, China); accuracy of
measurement was 1 μm; surface properties were examined using a
DSA-25E drop shape analyzer (Krüss, Germany) and software DSA-4
for Windows [34]. A minimum of six measurements were taken for
each surface; means and standard deviations were calculated.
To study the surface of the sample more carefully, the investigation
was carried out with a scanning electron microscope S-5500 (Hitachi,
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Siberian Branch of Russian Academy of Sciences. Prior to the analysis,
the ﬁlms were freeze-dried in an ALPHA 1-2/LD freeze dryer (Martin
Christ GmbH, Germany) for 24 h. Samples (5 × 5 mm) were placed
onto the sample stage and sputter-coated with platinum, using an
Emitech K575X sputter coater (10 mA, 2 × 40 s). Fiber diameters were
measured by analyzing SEM images with image analysis program
Image Processing and Data Analysis in Java (ImageJ). The diameters of
50 individual ultraﬁne ﬁbers were then measured in each SEM micro-
graph. Diameters were analyzed in 10 ﬁelds of SEM images in triplicate.
The elemental composition of the BC/P(3HB/4HB) was examined
using scanning electron microscopy (a TM-3000 Hitachi microscope
with the system QUANTAX 70 program).
Thermal analysis of samples was performed using a DSC-1 differen-
tial scanning calorimeter (METTLER TOLEDO, Switzerland). Powdered
samples (4.0 ± 0.2 mg each) were placed into the aluminum crucible
and compressed prior to measurement. Every sample was measured
at least 3 times. Samples were preheated to 60 °C and cooled to 25 °C.
The samples were heated to temperatures from 25 °C to 300 °C, at 5
°C × min−1 (measurement precision 1.5 °C); melting point (Tm) and
thermal decomposition temperature (Td) were determined from exo-
thermal peaks in thermograms. The thermograms were analyzed
using the STARe v11.0 software.
X-Ray structure analysis and determination of crystallinity of the BC
composites were performed employing a D8 ADVANCE X-Ray powder
diffractometer equipped with a VANTEC fast linear detector, using
CuKa radiation (Bruker, AXS, Germany). In order to determine the crys-
tallinity (Cx) of BC, the spectra were collected from a Vantec high-speed
detector, with exposure time of 3000. The detector was operated at
40 kV and 40 mA.
BC ﬁlms were sterilized with H2O2 plasma in a Sterrad NX medical
sterilizer (Johnson & Johnson, U.S.) and investigated in cell culture
assays.2.4. Loading of cells and wound-healing drugs into BC/P(3HB/4HB)
composites
To prepare composites loaded with cells, 10-mm-diameter BC/P
(3HB/4HB) disks were placed into 24-well culture plates (TPP
Techno Plastic Products AG, Switzerland) and sterilized in a Sterrad
NX medical sterilizer (Johnson & Johnson, U.S.). Fibroblasts were de-
rived from the adipose tissue MSCs of Wistar rats. The adipose tissue
cells were isolated enzymatically. The adipose tissue was rinsed in a
DPBS solution with antibiotics, ground, and incubated in a type I col-
lagenase solution (100 units/mL) at 37 °C until tissue particles were
dissolved, but for no more than 1 h. Then, collagenase was
inactivated with an albumin solution, centrifuged, and rinsed in the
DMEM medium several times, until the lipid layer had been
completely removed. The settled cells were suspended and seeded
onto Petri dishes that contained the DMEM medium (Gibco) with
10% fetal bovine serum (HyClone) and a solution of antibiotics: pen-
icillin, streptomycin, and Amphotericin B (Gibco). On the DMEMme-
dium, adipose tissue cells showed ﬁbroblast-like morphology. After
3–4 passages, the cells were removed from the Petri dishes with a
trypsin solution (Gibco) and seeded onto sterile BC/P(3HB/4HB)
disks: 105 cells per disk.
Loading of BC/P(3HB/4HB) composites with drugs promoting
wound healing was performed using solutions of actovegin (Takeda
Pharmaceuticals, Russia) and solcoseryl (MEDA Pharma, Switzerland).
Sterile composite samples were exposed to phosphate-buffered saline
(PBS) to investigate drug release. Under aseptic conditions, the samples
were placed into vials, each containing 50mL saline at pH=6. The vials
were incubated in a thermostat for 72 h at a temperature of 37 °C. The
experimentwas donewith samples 1 cm in diameter preparedwith dif-
ferent percentages of drugs (1%–5%).2.5. A study of biological compatibility of BC/P(3HB/4HB) composites in cell
culture
BC/P(3HB/4HB) samples loaded with drugs were shaped as 10 mm-
diameter disks. They were placed into 24-well culture plates (TPP
Techno Plastic Products AG, Switzerland) and sterilized in a Sterrad
NX medical sterilizer (Johnson & Johnson, U.S.). Scaffolds were seeded
with cells at 105 cells per scaffold for 7 days. Cells were cultured on
the DMEMmediumwith 10% fetal bovine serum (HyClone) and a solu-
tion of antibiotics (Gibco reagents) in the 5% CO2 atmosphere at 37 °C,
with the medium replaced by the fresh one every three days. For MTT
assay, 5% MTT-bromid solution (50 μl) and complete nutrient medium
(950 μl) were added to each well of the culture plate. After 4 h cultiva-
tion, the medium andMTT solution were replaced by DMSO to dissolve
MTT-formazan crystals. After dissolution of MTT-formazan crystals, 100
μl of supernatant was transferred to the 96-well plate, and optical den-
sity of the samples was measured at wavelength 540 nm, using iMark
microplate reader (Bio-Rad LABORATORIES Inc., U.S.). The number of vi-
able cells was determined from the calibration graph.2.6. An in vivo study of BC/P(3HB/4HB) composites and hybrids as experi-
mental wound dressings
Experimentswere conducted in accordancewith Russian State Stan-
dard (GOST R ISO) 10993-1-2009 “Medical products. Estimating biolog-
ical effects of medical products” and the international regulations
International Guiding Principles for Biomedical Research Involving Ani-
mals (CIOMS, 1985), WMA Declaration of Helsinki on treating research
animals with respect (2000), European Convention for the Protection of
Vertebrate Animals used for Experimental andOther Scientiﬁc Purposes
(Strasburg, 18.03.1986, ratiﬁcation date 01.01.1991, CETS No. 123). The
protocol of the experiments was approved by the Local Ethics Commit-
tee at the Siberian Federal University. The research animals were main-
tained and used in accordance with the rules accepted in the Russian
Federation. The efﬁcacy of the wound dressings based on BC and P
(3HB/4HB) with and without ﬁbroblasts differentiated from the
adipose-derived MSCs was evaluated in experiments on research ani-
mals with model skin defects (burns) and compared to the efﬁcacy of
commercial wound dressings VoskoPran (Biotekfarm, Russia).
Sexually mature female Wistar rats were kept in the animal facility
and fed their usual diet. The rats were anesthetized with 0.5–0.7 ml of
a 1% solution of sodium thiopental administered intraperitoneally.
Then the animals were placed on their backs, and a 1 cm2 section of
the skin was shaved. The burn was done with a 16-mm-diameter steel
plate preheated in boiling water for 10 min to 100 °C. The exposure
lasted 8 s to create a second-degree skin burn (in accordance with
ICD-10). After 5–10 min, the epidermis was separated from the under-
lying dermis with a sterile gauze swab. The animals were divided into
4 groups, 6 rats per group. In the treatment groups, three types of exper-
imental wound dressings were used: BC/P(3HB/4HB), BC/P(3HB/4HB)/
actovegin, and P(3HB/4HB)/BC/ﬁbroblasts. The dressings were ﬁxed
with single surgical sutures around wound edges. In the control group,
the wounds were covered with polyamide mesh VoskoPran.
After thewoundswere closed, each ratwas placed in a separate cage
for 14 days. The animals were euthanized with a lethal dose of Zoletil.
Evaluation of the efﬁcacy of the wound dressings was based on the in-
tensity of the inﬂammatory response in the wound and surrounding
soft tissues and the rate and completeness of skin repair.
Changes in the area of the wound surface were monitored by L.N.
Popova's method [35], to determine the wound healing rate. At Days
3, 7, and 14 of the treatment, the animals were sacriﬁced and skin sam-
ples were removed and used in histology. Tissue layers with edges from
thewound site were sectioned and ﬁxed in a 10% formalin solution. The
samples were processed by conventional procedure and embedded in
parafﬁn. Histological sectionswere stainedwith hematoxylin and eosin.
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using molecular methods, we detected the factors that characterized
the degree of inﬂammatory process, vascularization, and formation of
the new connective tissue at the defect site: angiogenesis (VEGF), in-
ﬂammation (TNF-a), type I collagen (Col-1) (an indicator of connective
tissue formation), keratin 10 (K10), and keratin 14 (K14). Gene expres-
sion of type I collagen (Col-1) was determined by real time RT-PCR, to
conﬁrm the ﬁbroblast phenotype of the cells and their viability. The
cells were lysed, andmRNAwas extracted using an RNA-Extran reagent
kit (Sintol, Russia). The cDNA was synthesized by reverse transcription
reaction using MMLV reverse transcriptase (Sintol, Russia). RT-PCR
was performed with the corresponding primers using a Real-time
CFX96 Touch detection system (Bio-Rad LABORATORIES Inc., U.S.) fol-
lowing the manufacturer's instructions. The housekeeping gene was
β-actin. The comparative threshold cycle method (2–ΔΔCt) was used
to determine the relative level of expression of the marker genes.
Total RNA was isolated from the granulation tissue of the treatment
and control groups by extraction with a guanidinium thiocyanate-
phenol-chloroform mixture from the RNA-Extran reagent kit. Then,
from the RNA template, using reverse transcriptase, we synthesized
cDNA with several types of oligonucleotide primers: with a mixture of
random primers – hexa primers – and oligo-dT primer, following the
procedure recommended by the manufacturer (Sintol). Negative con-
trols of reverse transcription reaction were prepared for all samples, to
conﬁrm the absence of DNA contamination in the initial RNA. Real-
time PCR-ampliﬁcation for quantiﬁcation of cDNA fragments of rat
VEGF, rat TNF-a, rat Col-1, rat K10, and rat K14 was performed by
using a CFX-96 thermocycler, according to the manufacturer's protocol,
using the color channel of HEX.
2.7. Statistical analysis
Statistical analysis of the results was performed using electronic ta-
bles inMicrosoft Excel 2010 and the Statistica 6.0 program for theWin-
dows XP operating system. Comparison of two related groups for
quantitative attributes was performed using the parametric method
with theWilcoxon matched pairs test. Comparison of two independent
groups for quantitative attributes was performed using the nonpara-
metric method with the Mann-Whitney U test. If the probability was
greater than 95%, the differences were considered as statistically
signiﬁcant.Fig. 1. Photographs of composite BC/P(3HB/4HB) ﬁlms prepared using different methods: 1 – B
solution, soaked for 24 h; 4 –wet BC + 2% P(3HB/4HB) solution; 5 – P(3HB/4HB) + BC powd3. Results and discussion
3.1. Production and properties of BC/P(3HB/4HB) hybrids
Composites based on BC and P(3HB/4HB) were constructed using
different methods. Photographs of the samples are shown in Fig. 1 and
SEM images in Fig. 2.
Samples prepared by adding nonwoven P(3HB/4HB) membranes
and BC powder to the culture of acetic acid bacterium and samples pro-
duced by impregnation of BC ﬁlms with a 5% solution of P(3HB/4HB)
had no distinct structure and showed poor mechanical properties
(Table 1).
The BC/P(3HB/4HB) composites prepared by submerging nonwoven
membranes into theK. xylinusB-12068 culture had the highestmechan-
ical strength (Young's modulus of 272.3 ± 27.2 MPa). The most likely
reason for this is the high mechanical strength of the nonwoven mem-
branes (113.54±9.85MPa). The values of Young'smodulus of the com-
posites prepared by soaking BC ﬁlms in the 2% P(3HB/4HB) solution
were 115 and 146 MPa, and they were higher than Young's modulus
of the initial P(3HB/4HB) ﬁlm. Although Young's modulus of the com-
posites prepared by mixing the polymer solution and BC powder was
low, it was higher than the corresponding parameter of pure BC
(47.60 ± 6.32 MPa), but elongation at break of the P(3HB/4HB) + BC
powder (1:1) (2:1) composites (3.45 ± 0.34%) was insigniﬁcantly
lower than elongation at break of the initial BC ﬁlm (4.35 ± 0.82%).
The data reported in a number of studies suggested that BC/P(3HB/
4HB) composites prepared using differentmethods had better mechan-
ical properties than pure BC. In a study by Zhijiang et al. [31], the me-
chanical properties of the nonwoven ﬁber based on P3HB and
cellulose acetate produced by electrospinningwere better than theme-
chanical properties of the nonwoven ﬁber based on cellulose acetate.
With PHB content increasing from 60% to 90% in the blend nanoﬁber,
the tensile strength, elongation at break, and Young's modulus in-
creased from 4.52 ± 0.34 MPa, 6.53 ± 0.48%, and 806.9 ± 168.2 MPa
to 7.86± 0.67MPa, 16.7± 1.52%, and 854.2 ± 187.6 MPa, respectively.
In a study by Akaraonye et al. [29], the compressive modulus of porous
composites based on P3HB was 0.08 ± 0.01 MPa, but the addition of
microﬁbrillated cellulose (10, 20, 30, and 40 wt%) increased it by 35%,
37%, 64%, and 124%, respectively.
BC/poly(3-hydroxybutyrate) (PHB) composites with different PHB
contents (25–90 wt%) were prepared by Barud et al. [27] from BCC+ 2% P(3HB/4HB) solution; 2 – BC+ 5% P(3HB/4HB) solution; 3 – BC+ 2% P(3HB/4HB)
er (2:1); 6 – P(3HB/4HB) + BC powder (1:1).
Fig. 2. SEM images of the surface of BC/P(3HB/4HB) composites prepared by different methods (sample indexing is the same as in Fig. 1).
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nanoﬁbrils involved PHB pellets precipitated inside the BC network.
Better tensile properties were observed for composite membranes
than for any of the isolated polymers, producing tensile strength and
modulus as high as 144 MPa and 15.5 GPa, respectively (with 25%
PHB), and elongation of up to 9.5% (with 75% PHB), due to good interfa-
cial adhesion and strong interactions between BC and PHB chains.
Zhijianga et al. [28] prepared composite ﬁlms from a 4% solution of
P3HB with poly-3-hydroxyhexanoate, 3-hydroxyoctanoate, and 3-
hydroxydecanoate tetrapolymer (95:5) with BC powder that showed
Young's modulus of between 3000 and 3080 MPa, depending on BC
concentration in the ﬁlms (1, 2, and 5 wt%). The neat P3HB ﬁlm had
Young's modulus of 3160 MPa. By contrast, the tensile strength in-
creased with the addition of PHA and BC at lower concentrations,
from26.7 to 22.9MPa. Thus, physical/mechanical properties of compos-
ite scaffolds based on PHA and BC are superior to the properties of neat
PHA ﬁlms, and they are largely determined by the methods of produc-
tion of the composite and the properties of the PHA used.
BC ﬁlm is rather hydrophilic, with water contact angle of 45.5 ±
17.6°, while water contact angle of P(3HB/4HB) ﬁlm is 66.5 ± 4.4
(Table 2).
Soaking of the BC ﬁlm in a 2% P(3HB/4HB) solution produced an in-
signiﬁcant effect on the surface properties of BC. Composites prepared
by mixing the P(3HB/4HB) solution and BC powder at ratios of 2:1
and 1:1 had water contact angles of 43.9 ± 17.55 and 36.1 ± 0.66°, re-
spectively; the dispersive and polar components were larger than those
of pure BC, suggesting higher hydrophilicity of the surface of compos-
ites. The reason for the high values of water contact angle of the BC/P
(3HB/4HB) nonwoven membrane composites, 65.3 ± 2.72°, was that
the nonwoven membranes used to grow cellulose were initially dense,Table 1
Physical/mechanical properties of the BC/P(3HB/4HB) hybrids.
Sample Young's modu
Initial P(3HB/4HB) 1112.34 ±
Initial BC 47.60 ±
Nonwoven membranes 113.54 ±
BC + nonwoven membranes 272.3 ±
P(3HB/4HB) + BC powder (2:1) 65.08 ±
P(3HB/4HB) + BC powder (1:1) 63.41 ±
BC +2% P(3HB/4HB) solution 115.99 ±
BC (moisture content 95–97%) + 2% P(3HB/4HB) solution 146.76 ±with the water contact angle of about 60.5 ± 4.4°. After drying, the
ﬁlms impregnatedwith a 5% P(3HB/4HB) solution had a very rough sur-
face and a non-uniform coating, making it impossible to examine their
surface properties.
A similar though less pronounced decrease in the surface hydropho-
bicity of P3HB/BC composites was noted by Chiulan et al. [30]. Incorpo-
rating BC, which is a hydrophilic material, led to a decrease of the
contact angle with 3 for the dried PHB + tetrapolymer/BC (72.3 ± 6
3.9) sample as compared with PHB-A matrix (77.4 ± 6 2.4). With CA
content increasing in the blend nanoﬁber scaffold, the contact angle
tended to decrease and the scaffold surface was gradually transformed
from hydrophobicity to hydrophilicity [31]. When the CA content was
40%, the PHB/CA blend nanoﬁber scaffold was quite hydrophilic with
contact angle of 60 ± 1.25°.
An important parameter of wound dressings is water vapor trans-
mission rate – ameasure of the passage of water vapor through thema-
terial. The experimental composites showed different water vapor
transmission rates: for the P(3HB/4HB) + BC powder (2:1), it was the
highest (5014 ± 20 g/m2/d), while for the P(3HB/4HB) ﬁlm, it was the
lowest (404 ± 9.1 g/m2/d). It is important to increase this parameter
to control the buildup of ﬂuid underneath the dressing, make it more
breathable, and prevent the establishment of conditions favorable for
the development of pathogenic microorganisms.
Thus, in vitro and in vivo experiments were performed using BC/P
(3HB/4HB) composite ﬁlms prepared bymethod 4 (powdered cellulose
(particle size of 120 μm) was added to a 3% P(3HB/4HB) solution in
chloroform and mixed ultrasonically to homogeneity; then, ﬁlms were
produced by the solvent evaporation technique, at polymer to cellulose
ratios of 2:1). These composites were superior to BC ﬁlms in their phys-
ical/mechanical properties; they had hydrophilic surface, adsorptionlus, MPa Fracture strength, MPa Fracture strain,%
23.3 5.33 ± 1.02 10.70 ± 6.32
6.32 0.11 ± 0.13 4.35 ± 0.82
9.85 9.30 ± 1.24 180.33 ± 20.71
27.2 8.67 ± 0.86 3.65 ± 0.4
7.1 0.88 ± 0.08 3.45 ± 0.34
5.6 0.83 ± 0.07 3.47 ± 0.57
10.9 6.65 ± 1.2 6.25 ± 0.94
14.6 5.63 ± 0.82 5.71 ± 1.3
Table 2
Surface properties of BC/P(3HB/4HB) hybrids.
Sample Water contact angle, degrees Dispersive component, mN/m Polar component, mN/m Water vapor transmission rate, g/m2/d
Initial BC 45.5 ± 17.6 28 ± 9.24 17.5 ± 8.37 2655 ± 21
P(3HB/4HB) ﬁlm 66.5 ± 4.4 22.90 ± 17.6 42.2 ± 17.6 404 ± 9.1
P(3HB/4HB) nonwoven membrane 60.5 ± 4.4 22.40 ± 15.0 12.2 ± 10.5 1000 ± 7
BC +2% P(3HB/4HB) solution 46.2 ± 13.77 45.2 ± 11.74 21 ± 2.03 4473 ± 10
P(3HB/4HB) + BC powder (2:1) 43.9 ± 17.55 22 ± 9.39 21.9 ± 8.17 5014 ± 20
P(3HB/4HB) + BC powder (1:1) 36.1 ± 0.66 35.5 ± 0.58 29.6 ± 0.08 1732 ± 9
BC + nonwoven membrane 65.3 ± 2.72 45.6 ± 1.29 19.7 ± 1.42 2005 ± 15
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ﬁrmed by electron microscopy.
3.2. Biological properties of BC/P(3HB/4HB) hybrids
Biological compatibility of BC/P(3HB/4HB) composites was studied
in ﬁbroblast culture. MTT assay showed that the best scaffolds for ﬁbro-
blast growth were the ﬁlms prepared by the solvent evaporation tech-
nique at a polymer: cellulose ratio of 2:1 (Fig. 3).
The ability of P(3HB)/BC composites to facilitate growth and prolif-
eration of ATDC5 cells was described in a study by Zhijiang et al. [31].
Nonwoven PHB/CA composites favored cell proliferation more effec-
tively than PHB after 72 h of cultivation. In a study by Akaraonye et al.
[29], the P(3HB)/MFC 3D composite scaffold with 40 wt% MFC content
showed a slightly lower cell proliferation at day 4 (97%) compared to
the neat P(3HB) scaffold samples (108%). At day 7, however, it was
found that the cell proliferation on the 40 wt% MFC content composite
was higher (117%) than that observed on the neat P(3HB) scaffold
(105%).
In the present study, investigation of physical/mechanical and bio-
logical properties of the experimental hybrids showed that the ﬁlms
prepared by casting the solutions of the polymer: cellulose powdermix-
ture (2:1) followed by solvent evaporation were the most attractive
candidates to be used as scaffolds for growing ﬁbroblasts. These types
of hybrids were loaded with drugs promoting wound healing
(actovegin, solcoseryl) and ﬁbroblasts derived from the adipose tissue
MSC (Fig. 3). Hybrids loaded with 5.0% actovegin or solcoseryl were
the most favorable for ﬁbroblast growth.
The study of the kinetics of drug (actovegin, solcoseryl) release from
the BC/P(3HB/4HB) ﬁlms to the phosphate-buffered saline showed that
the drugs were released at a faster rate from the ﬁlms containing higher
drug concentrations. Although actovegin and solcoseryl are drugs with
similar effects, after 72 h, 0.47 mg/mL, or 43%, of the drug was released
from the ﬁlms loadedwith 5% actovegin and just 0.11mg/mL, or 21%, of
solcoseryl was released from the ﬁlms with the same drugFig. 3. MTT assay: viable ﬁbroblasts on hybrid BC/P(3HB/4HB) ﬁlms: 1 – control
(polystyrene); 2 – BC + nonwoven membrane; 3 – BC + 2% P(3HB/4HB) solution; 4 – P
(3HB/4HB) + BC powder (2:1); 5 – P(3HB/4HB) + BC powder (1:1); 6 – P(3HB/4HB)
+ BC powder (2:1) + actovegin (5.0%); 7 – P(3HB/4HB) + BC powder (2:1) +
actovegin (1.0%); 8 – P(3HB/4HB) + BC powder (2:1) + solcoseryl (5.0%); 9 – P(3HB/
4HB) + BC powder (2:1) + solcoseryl (1.0%).concentration. Therefore, ﬁlms loaded with 5% actovegin were chosen
for further studies (Fig. 4).3.3. In vivo experiment
Models of third-degree skin burns were created on anesthetized
rats. The animals were divided into 4 groups, 6 rats in each group. In
the control group, the defect was closed with a VaskoPran dressing
and covered with a dry sterile gauze bandage. In treatment groups,
three types of the experimental wound dressings were used: BC/P
(3HB/4HB), a BC/P(3HB/4HB)/actovegin and a BC/P(3HB/4HB)/ﬁbro-
blasts differentiated from MSCs wound dressing.
After surgical intervention, all animals were healthy and active,
displayed normal eating behavior, and moved on their own. After the
treatment group animals awakened from anesthesia, they did not
show any signs of pain. Wound healing process was monitored using
the following approaches: planimetric measurements of the wounds
and determination of wound surface area reduction and healing rate;
histological examination; biochemical and molecular techniques of de-
tecting angiogenesis factor, inﬂammation, type I collagen, keratin 10,
and keratin 14. Measurements of the wound surface area showed that
wound healing occurred at a faster rate in the treatment groups
(Figs. 5, 6).
The surface area of the wound closed with the BC/P(3HB/4HB)/
actovegin wound dressing was reduced to 1 cm2 (67% of the initial
area) at Day 3, to 33% at Day 7, and to 7.3% at Day 14. A similar healing
process was observed in the group with the BC/P(3HB/4HB)/ﬁbroblasts
wound dressings: thewound areawas reduced to 69.3% at Day 3, to 40%
at Day 7, and to 9% at Day 14. The heling rates in these groupswere sim-
ilar too, about 0.4 cm2/d. In the group with the wounds closed with the
BC/P(3HB/4HB) ﬁlms containing no cells or actovegin, the healing rate
was somewhat slower, with the wound area reduced to about 12% of
the initial area by the end of the experiment. In the control group, a
much poorer result was obtained: at Day 14, the wound area wasFig. 4. The drug release (actovegin, solcoseryl) from the BC/P(3HB/4HB) ﬁlms: 1 – P(3HB/
4HB) + BC powder (2:1) + solcoseryl (1.0%), 2 – P(3HB/4HB) + BC powder (2:1) +
actovegin (1.0%); 3 – P(3HB/4HB) + BC powder (2:1) + solcoseryl (5.0%); 4 – P(3HB/
4HB) + BC powder (2:1) + actovegin (5.0%).
Fig. 5. Dynamics of reduction in the skin wound area in the groups of animals with
different wound dressings: 1 – VoskoPran (control), 2 – BC/P(3HB/4HB); 3 – BC/P(3HB/
4HB)/actovegin; 4 – BC/P(3HB/4HB)/ﬁbroblasts.
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0.19 cm2/d.
Histological examination showed that at Day 3, the necrotic zones in
all groups were characterized by considerable destructive changes of
the epidermis, dermis, and subcutaneous tissue, with the total necrosis
of skin appendages (Fig. 7). The surface of the wound was uneven and
covered by a layer of necrotic masses with residual epidermis. Under
the necrotic zone, in the layer adjacent to the undamaged tissue, there
was an edema pronounced to different extents, and inﬁltration domi-
nated by band neutrophils. In the control group, the thickness ofFig. 6. Photographs of burnwounds during the healing process in experiments with commercia
(3HB/4HB)/actovegin; 4 – BC/P(3HB/4HB)/ﬁbroblasts; Days 3, 7, and 14 of the experiment.epithelial injury (scab) was 28.45 ± 8.3 μm, and the number of band
neutrophils reached 10 ± 2 cells (in 10 ﬁelds of view). In the BC/P
(3HB/4HB) group, the scab was 20.29 ± 2.3-μm thick, and the number
of band neutrophils was 6 ± 2 cells (in 10 ﬁelds of view). In the BC/P
(3HB/4HB)/actovegin and BC/P(3HB/4HB)/ﬁbroblasts groups, the thick-
ness of the scab was 18.1 ± 1 μm, and the number of band neutrophils
was 6 ± 2 cells (in 10 ﬁelds of view). In the center of the burn, there
were no hair follicles and sebaceous glands or they showed pronounced
necrotic changes. There were no signs of regeneration in the center and
at the edges of the wounds.
At Day 14, in all groups, the thickness of the layer of necrotic masses
covering the wound was reduced (Fig. 8). In all treatment groups, the
wound bed was represented by ﬁbrous connective tissue with non-
uniformly distributed inﬁltration by lymphocytes, macrophages, and
segmented leukocytes. Rapid proliferation of ﬁbroblasts was observed
at the wound edges beneath the epidermis. It was accompanied by the
development of relatively few small blood vessels. In groupswithmem-
branes loadedwith actovegin andﬁbroblasts, either therewas no leuko-
cyte inﬁltration in the wound or it was represented by the minimal
number of segmented leukocytes (2 ± 1 cells in 10 ﬁelds of view). In
the control group, leukocyte inﬁltration on the wound bed, in the
layer adjacent to viable tissues, was still observed, but it was weaker
than in the previous phases of the experiment. Rapid epidermization
was observed in all groups, but in the treatment groups, it wasmore ef-
fective, especially in the groups with membranes loaded with agents
promoting wound healing (actovegin, ﬁbroblasts). In those groups,
the wounds were almost completely covered with a layer of epidermis
(Fig. 8).l material VoskoPran – 1 and experimental wound dressings: 2 – BC/P(3HB/4HB); 3 – BC/P
Fig. 7. Histological sections from the skin defect sites. Wound healing (Day 3 post defect creation) under different wound dressings: 1- commercial material VoskoPran; 2 – BC/P(3HB/
4HB); 3 – the BC/P(3HB/4HB)/actovegin hybrid membrane; 4 – the BC/P(3HB/4HB)/ﬁbroblasts hybrid membrane. Hematoxylin and eosin staining, 100×.
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(scab) covering the wound. In the marginal layer, epidermis formed
thin acantotic strands, which would later develop into hair follicles.
No granulation tissue was formed during epidermization. TheFig. 8.Histological sections collected at the defect site. Wound healing (Day 14 post defect crea
4HB); 3 – the BC/P(3HB/4HB)/actovegin hybrid membrane; 4 – the BC/P(3HB/4HB)/ﬁbroblastunderlying dermis contained fewmoderately plethoric arteries and en-
larged veins with a large number of erythrocytes. The inﬂammatory in-
ﬁltration outside the wound consisted of mononuclear cells; it was
moderate and did not spread beyond the dermis. In the control group,tion) under different wound dressings: 1- commercial material VoskoPran; 2 – BC/P(3HB/
s hybrid membrane. Hematoxylin and eosin staining, 100×.
Fig. 9. Relative expression of TNF-α genes (tumor necrosis factor, a protein involved in acute inﬂammation) and VEGF (vascular endothelial growth factor, an indicator of vasculogenesis
and angiogenesis) (results normalized relative to the housekeeping gene – β-actin) – indicators of the regeneration dynamics of skinwounds inWistar rats with hybridwound dressings:
1 – BC/P(3HB/4HB); 2 – BC/P(3HB/4HB)/ﬁbroblasts; 3 – BC/P(3HB/4HB)/actovegin; 4 – VoskoPran (control).
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bank,which penetrated to the underlying subcutaneous tissue in places.
Similar, thoughweaker, changes were observed in the animals with the
BC/P(3HB/4HB) wound dressings.
To study the mechanism of the healing process, real-time PCR was
performed to determine the factors characterizing the degree of inﬂam-
mation, vascularization, and formation of the new connective tissue at
the defect site. Relative expression of VEGF (vascular endothelial
growth factor, an indicator of vasculogenesis and angiogenesis) was
higher in the groups with hybrid membranes loaded with ﬁbroblasts
or actovegin (Fig. 9). In the BC/P(3HB/4HB)/actovegin group, ΔCt was
20% higher than in the VoskoPran group and 30% higher than in the
BC/P(3HB/4HB) group. In the group with the membranes loaded with
ﬁbroblasts, relative expression was 5–6% lower but it was also higher
than in the control group.Fig. 10. Relative expression of type I collagen (Col-1), keratin 10 (K10) and keratin 14 (K14
regeneration dynamics of skin wounds in Wistar rats with hybrid wound dressings: 1 – BC/P(
(control).Relative TNF-α (tumor necrosis factor, a protein involved in acute
inﬂammation) gene expression decreased considerably by the end of
the experiment (Fig. 10), and in the groups with membranes loaded
with ﬁbroblasts and actovegin, it was lower by a factor of two than in
the BC/P(3HB/4HB) and VoskoPran groups, suggesting alleviation of in-
ﬂammation. The PCRmethod was used to determine expression of type
I collagen (Col-1) (a signal of connective tissue formation), keratin 10
(K10) and keratin 14 (K14) (signals of formation of the spinous and
granular layers in the epidermis during tissue regeneration) genes.
The number of Col-1, K10, and K14 cDNA copies was higher than that
in the control by a factor of 1.5–2.0, also suggesting more effective
wound healing beneath the experimental hybrid wound dressings.
The results of experiments in which the BC-based composites were
tested as wound dressings are consistent with the literature data sug-
gesting BC effectiveness in healing skinwounds. However, other studies) (results normalized relative to the housekeeping gene – β-actin) – indicators of the
3HB/4HB); 2 – BC/P(3HB/4HB)/ﬁbroblasts; 3 – BC/P(3HB/4HB)/actovegin; 4 – VoskoPran
Fig. 11.
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Bajpai et al. [10] demonstrated 97.2% healing of full-thickness skin
wounds in Albino Wistar rats under a ﬁlm of BC nanocrystals/chitosan
incorporating silver and curcumin particles. Potential use of BCmodiﬁed
with carboxymethyl groups and loadedwith chitosan particles with en-
capsulated curcumin as material for healing skin wounds was shown in
a study by Rojewska et al. [11]. Gelatin/BC scaffolds accelerated healing
of skin wounds in mice [12]; BC composites with silk ﬁbroin effectively
healedmodel skinwounds in rats [13], and that was conﬁrmed bymea-
suring the levels of expression of wound healing markers. Singla et al.
[14] used hydrogels prepared from bamboo cellulose nanocrystals
loaded with silver particles to heal skin wounds in streptozotocin in-
duced diabetic mice. Wounds were 98–100% recovered within 18 days
as conﬁrmed by detecting molecular markers of tissue genesis and a
signiﬁcant increase in the expression of collagen and growth factors
(FCF, PDGF, and VEGF), which caused enhanced re-epithelization,
vasculogenesis, and collagen deposition (Fig. 11).
In a study by Kwak et al. [5], the second-degree 1 cm2 burn injury in
a ratmodelwas closedwith a bacterial cellulosemembrane. The expres-
sion of VEGF and angiopoietin-1 (Ang-1) was considerably decreased at
Days 10 and 15. Moreover, the level of collagen expression was much
higher in the BC group than in the group of rats with thewounds closed
with gauze. Although the topical application of bacterial cellulosemem-
branes for two weeks accelerated wound healing, including tissue re-
generation, connective formation, and angiogenesis, no complete skin
healing occurred. In a study by Lin et al. [2], membranes based on bacte-
rial cellulose and chitosan and on cellulose alonewere used to close 1.2-
cm × 1.2-cm degloving wounds in rats. The wounds were 90 and 88%
healed under the composite material and cellulose, respectively, after
21 days of the experiment. The authors concluded that skin regenera-
tion should be accelerated by adding agents promoting wound healing
(drugs or cells).
4. Conclusion
Thus, results obtained in this study suggest that biotechnological
wound dressings based on bacterial cellulose and P(3HB/4HB) in com-
bination with wound healing drugs and cells are effective in managing
skin wounds.
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